155 related articles for article (PubMed ID: 25355558)
21. A Case-Control Study on the Correlation Between Thymidylate Synthase Gene Polymorphisms and Raltitrexed Treatment Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Treatment.
Qi C; Gao H; Li S; Zong H; Hao H; Zhang L
Genet Test Mol Biomarkers; 2020 Mar; 24(3):156-164. PubMed ID: 32101052
[No Abstract] [Full Text] [Related]
22. CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE.
Zhang JW; Feng XY; Liu HQ; Yao ZW; Yang YM; Liu B; Yu YQ
World J Gastroenterol; 2010 Apr; 16(16):2038-45. PubMed ID: 20419843
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of patients with hepatocellular carcinoma treated solely with transcatheter arterial chemoembolization: risk factors for one-year recurrence and two-year mortality (preliminary data).
Matsuda M; Omata F; Fuwa S; Saida Y; Suzuki S; Uemura M; Ishii N; Iizuka Y; Fukuda K; Fujita Y
Intern Med; 2013; 52(8):847-53. PubMed ID: 23583987
[TBL] [Abstract][Full Text] [Related]
24. Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma.
Lyu Z; Chen Y; Guo X; Zhou F; Yan Z; Xing J; An J; Zhang H
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):698-704. PubMed ID: 27288297
[TBL] [Abstract][Full Text] [Related]
25. The Expression and Prognostic Value of Cancer Stem Cell Markers, NRF2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma.
Tseeleesuren D; Hsiao HH; Kant R; Huang YC; Tu HP; Lai CC; Huang SF; Yen CH
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208536
[No Abstract] [Full Text] [Related]
26. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
Huang ZM; Lai CX; Zuo MX; An C; Wang XC; Huang JH; Ning E
J Cancer Res Ther; 2020; 16(7):1603-1610. PubMed ID: 33565506
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Zhang JB; Chen Y; Zhang B; Xie X; Zhang L; Ge N; Ren Z; Ye SL
Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):787-93. PubMed ID: 21730869
[TBL] [Abstract][Full Text] [Related]
28. Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma.
Ma XL; Jiang M; Zhao Y; Wang BL; Shen MN; Zhou Y; Zhang CY; Sun YF; Chen JW; Hu B; Gong ZJ; Zhang X; Cao Y; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Ann Surg Oncol; 2018 Jun; 25(6):1686-1694. PubMed ID: 29626309
[TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
31. Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization.
Prajapati HJ; Kim HS
PLoS One; 2017; 12(2):e0170750. PubMed ID: 28170405
[TBL] [Abstract][Full Text] [Related]
32. Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinoma.
Liu S; Yang TB; Nan YL; Li AH; Pan DX; Xu Y; Li S; Li T; Zeng XY; Qiu XQ
Cancer Med; 2017 Jul; 6(7):1512-1522. PubMed ID: 28639733
[TBL] [Abstract][Full Text] [Related]
33. Which system is better to predict prognosis of patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization as initial therapy? Comparison between CLIP and JIS in a Japanese population.
Urakawa H; Kora SI; Mitsufuji T; Osame A; Higahsihara H; Yoshimitsu K
Acta Radiol; 2016 Dec; 57(12):1445-1452. PubMed ID: 26861204
[TBL] [Abstract][Full Text] [Related]
34. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
[TBL] [Abstract][Full Text] [Related]
35. Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
Hiraoka A; Ishimaru Y; Kawasaki H; Aibiki T; Okudaira T; Toshimori A; Kawamura T; Yamago H; Nakahara H; Suga Y; Azemoto N; Miyata H; Miyamoto Y; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
Oncology; 2015; 89(3):167-74. PubMed ID: 25999038
[TBL] [Abstract][Full Text] [Related]
36. Associations between single nucleotide polymorphisms in RYBP and the prognosis of hepatocellular carcinoma in a Chinese population.
Zhu X; Wang Z; Qiu X; Tan C; Yu H; Bei C; Qin L; Ren Y; Tan S
Carcinogenesis; 2017 May; 38(5):532-540. PubMed ID: 28369212
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma.
Lin ZH; Jiang JR; Ma XK; Chen J; Li HP; Li X; Wu XY; Huang MS; Lin Q
Clin Exp Med; 2021 Feb; 21(1):109-120. PubMed ID: 33037574
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.
Lautem A; Simon F; Hoppe-Lotichius M; Mittler J; Vollmar J; Schad A; Düber C; Galle PR; Otto G; Zimmermann T; Lang H
Oncol Rep; 2019 Apr; 41(4):2299-2310. PubMed ID: 30720132
[TBL] [Abstract][Full Text] [Related]
39. β-Catenin Expression Correlates With Prognosis in Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization.
Xu X; Gao D; Yuan X; Liu LI; Zhang X; Liang X; Chen S; Ai M; Chen BO; Shi D; Yang Z; Hoffman RM; Xu J
Anticancer Res; 2019 Mar; 39(3):1129-1134. PubMed ID: 30842141
[TBL] [Abstract][Full Text] [Related]
40. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization.
Wang ZX; Li J; Wang EX; Xia DD; Bai W; Wang QH; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH
World J Gastroenterol; 2020 Apr; 26(15):1805-1819. PubMed ID: 32351295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
